RIGEL PHARMACEUTICALS INC·4

Jun 3, 6:01 PM ET

Furey Raymond J. 4

4 · RIGEL PHARMACEUTICALS INC · Filed Jun 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Rigel (RIGL) EVP Raymond Furey Surrenders 877 Shares for Taxes

What Happened

  • Raymond J. Furey, EVP, General Counsel, Chief Compliance Officer & Corporate Secretary of Rigel Pharmaceuticals (RIGL), disposed of 877 shares on 2026-06-01 to satisfy tax liabilities tied to equity compensation. The per-share value reported was $29.86, for a total of $26,187.
  • This was a share-for-tax withholding (reported with transaction code F), not an open-market sale.

Key Details

  • Transaction date: 2026-06-01; Filing date: 2026-06-03 (Form 4 filing appears timely).
  • Price used for withholding: $29.86 per share.
  • Shares disposed: 877; value: $26,187.
  • Transaction code: F — payment of exercise price or tax liability (shares surrendered/withheld to cover taxes).
  • Shares owned after the transaction: not specified in the provided filing excerpt; check the full Form 4 for post-transaction holdings.
  • Not a 10b5-1 sale or gift; this is routine tax withholding associated with equity compensation.

Context

  • Shares withheld to cover taxes are a common administrative step after option exercises or restricted stock vesting. They represent a tax payment, not necessarily a signal of the insider’s view on the company’s stock.
  • If you want the full holdings and additional notes, consult the complete Form 4 filing (Accession: 0000905148-26-002807) on the SEC EDGAR site.

Insider Transaction Report

Form 4
Period: 2026-06-01
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Transactions
  • Tax Payment

    Common Stock

    2026-06-01$29.86/sh877$26,18750,936 total
Signature
/s/ Raymond Furey|2026-06-03

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4